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Abstract
Field immobilization of native or invasive wild pigs (Sus scrofa) is challenging. Drug combinations commonly used often result
in unsatisfactory immobilization, poor recovery, and adverse side effects, leading to unsafe handling conditions for both animals
and humans. We compared four chemical immobilization combinations, medetomidine–midazolam–butorphanol (MMB),
butorphanol–azaperone–medetomidine (BAM™), nalbuphine–medetomidine–azaperone (NalMed-A), and tiletamine–
zolazepam–xylazine (TZX), to determine which drug combinations might provide better chemical immobilization of wild pigs.
We achieved adequate immobilization with no post-recovery morbidity withMMB. Adequate immobilization was achieved with
BAM™; however, we observed post-recovery morbidity. Both MMB and BAM™ produced more optimal results relative to
body temperature, recovery, and post-recovery morbidity and mortality compared to TZX. Adequate immobilization was not
achieved with NalMed-A. Of the four drug combinations examined, we conclude that MMB performed most optimally for
immobilization and recovery of wild pigs.
Keywords Wild pig . Chemical immobilization .Medetomidine .Midazolam . Butorphanol
Introduction
Capturing and handling wild pigs (Sus scrofa; referred to in the
literature as feral swine/pigs/hogs/wild boar/swine, wild swine/
pigs/hogs/boar/boar–feral pig hybrids, Eurasian wild boar,
European wild boar, European swine) (Price 1984; Nolte and
Anderson 2015; Keiter et al. 2016; Sweitzer et al. 2016;
McCann et al. 2018) for field research focusing on behavior,
ecology, movement, or other study objectives present a variety
of challenges as such studies typically involve manipulations
including attachment of monitoring devices (e.g., radio collars,
proximity loggers), sample collection, and translocation,
followed by release back into the environment. Development
of field research study plans should occur under the guidance
of an institutional animal care and use committee (IACUC) and
may include a risk analysis to improve study implementation
and outcomes (Swart 2004; FASS 2010; Paul et al. 2016).
While standard animal research guidelines and regulations
may not apply specifically to wildlife species, the basic goals
of ethical humane treatment, and limiting stress, distress, dis-
comfort, and pain to the animals must be considered by the
IACUC and the research team (William 1959; Smith and
Hawkins 2016). The risk analysis should include identification
of problems unique to wildlife research such as the inability to
accurately assess the age, weight, and health status of wild
animals, occurrence of adverse environmental conditions, trap-
ping and release strategies, handling and release stressors, and
other study-specific parameters.
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Development of all handling, sampling, capture and release
strategies, chemical immobilization, and analgesic regimens
should ensure animal and personnel safety. Use of chemical
immobilization agents improves efficiency and safety for ani-
mal handlers, enhances achievement of study objectives, and
decreases stress and other well-described detrimental physio-
logical responses (e.g., hyperthermia, traumatic injury) in wild
pigs. Selection of the most appropriate chemical immobiliza-
tion agents should be based upon the research study objectives,
external and internal factors associated with the study, cost,
immobilization agent pharmacological effects, immobilization
agent availability, safety of animal handlers and the animals,
guidance of the IACUC, and the results of the risk analysis.
External (e.g., ambient temperature, environmental condi-
tions, terrain, nearby water bodies or roads, capture tech-
niques, research study objectives) and internal factors (e.g.,
genetics, gender, age, disease, reproductive status), and the
pharmacological effects of the chemical immobilization
agents pre-, intra-, and post-immobilization affect the outcome
of wild animal immobilization events and research data qual-
ity (Wyckoff et al. 2006; Fenati et al. 2008; Barasona et al.
2013). Errors in weight estimation of wild pigs is not uncom-
mon (Fenati et al. 2008) and results in under- or over-dosage
of chemical immobilization agents. Over-dosage or adminis-
tration of supplemental doses of chemical immobilization
agents may result in impaired physiological responses (e.g.,
thermoregulation, respiration, circulation, mentation) during
and after sedation, and increased morbidity or death, especial-
ly agents that induce prolonged sedation and extended recov-
ery times and have no reversal agent(s) (Gabor et al. 1997;
Sweitzer et al. 1997a; Fenati et al. 2008). Post-mortem data are
often not collected following wild pig capture or chemical
immobilization mortalities; however, capture myopathy, hy-
perthermia, chemical immobilization, drug-induced cardio-
vascular collapse, and concomitant physiological or infectious
disease are suggested etiologies contributing to wild pig mor-
talities (Spraker 1982; Wyckoff et al. 2006; Fenati et al. 2008;
Barasona et al. 2013; Swindle and Smith 2015). Post-
immobilization hyperthermia occurring hours after recovery
from chemical immobilization has been reported in domestic
swine (Swindle and Smith 2015). It is unknown if this phe-
nomenon occurs in wild pigs; however, it is plausible given
this syndrome is associated with elevated blood lactate and
stress (Swindle and Smith 2015).
Drugs commonly used to immobilize wild pigs in the field
include combinations of tiletamine–zolazepam (TZ) plus
xylazine (X) and/or ketamine (K) (Sweitzer et al. 1997a;
Plumb 2008; Wyckoff et al. 2009; Barasona et al. 2013).
Tiletamine is a cyclohexamine compound that elicits central
nervous system dissociation, visceral analgesia, and superfi-
cial anesthesia (Plumb 2008). Adverse effects may include
muscle hypertonia and rigidity, tachycardia, vomiting, hyper-
tension, and erratic/prolonged recovery (Plumb 2008;
Carpenter 2013). Zolazepam is a benzodiazepine drug that
induces sedation, and has anxiolytic andmuscle relaxant prop-
erties; however, re-sedation can occur in animals receiving
large or multiple doses of zolazepam. Xylazine is an α2-
adrenergic agonist that provides sedation, visceral analgesia,
and muscle relaxation that may be reversed with α2-
adrenergic receptor antagonists such as atipamezole,
tolazoline, and yohimbine (Plumb 2008; Barasona et al.
2013). Ketamine is a cyclohexamine drug with rapid onset
of action (1–4 min) and short duration of action (12–
25min). Important adverse effects include hyperthermia, eme-
sis, and muscle hypertonia and rigidity. Potentiation of the
pharmacological effects of butorphanol and other opiates can
occur with this agent (Plumb 2008). Reversal agents are not
available for tiletamine or ketamine. The duration of action
and time to full recovery associated with TZ combinations are
long (tiletamine, 60–90 min; zolazepam, 1–5.5 h) in most
animal species, including swine (Plumb 2008; Kumar et al.
2014). Use of TZ in domestic and wild pigs has been observed
to elicit prolonged, rough recoveries that include traumatic
behaviors (e.g., paddling, struggling to achieve sternal recum-
bency or standing, staggering, collision with solid objects),
which may contribute to post-immobilization persistence of
hyperthermia, and the pathology of capture myopathy
(Gabor et al. 1997; Sweitzer et al. 1997a, 1997b; Enqvist
2000; Wyckoff et al. 2006; Kim et al. 2007; Fenati et al.
2008; Barasona et al. 2013).
The health and safety of animal handlers and study subjects
during handling events is important, especially when handling
large aggressive animals such as wild pigs. Use of appropriate
animal handling systems that minimize stress and injury to the
animals, and maximize human safety are critical. Efficacious
chemical immobilization agents with excellent immobiliza-
tion attributes, wide margins of safety, that result in good
sedation, quiet expedient recovery, and few prolonged post-
recovery sequelae are important adjuncts to the handling pro-
cess. Drugs with prolonged times to full recovery and delete-
rious post-recovery effects may affect animal behavior and
responses well beyond the time animals are perceived to be
“recovered” and released back to the environment.
Additionally, immobilization drugs and their metabolites can
persist in tissues for long periods of time (Swindle and Smith
2015) and as such may pose health risks to hunters.
It is of paramount importance to identify the most effective
tools available to minimize wildlife capture and handling
risks. This includes identification of chemical immobilization
agents that offer alternatives to the use of TZ, TZX, TKX, and
TZKX in wild pigs. Ideally, these alternatives would provide
improved deep sedation, muscle relaxation, adequate analge-
sia, capability for reversal, short duration of quiet recovery
and post-recovery behaviors, and discourage induction or ex-
acerbation of adverse physiological responses (e.g., hyperther-
mia, capture myopathy). Two drug combinations used
   78 Page 2 of 12 Eur J Wildl Res           (2019) 65:78 
successfully in other wildlife species include butorphanol–
azaperone–medetomidine (BAM™) and nalbuphine–
azaperone–medetomidine (NalMed-A) which have proved ef-
fective for immobilization of black bear (Ursus americanus),
elk (Cervus canadensis), bison (Bison bison), and ibex (Capra
nubiana) (Mich et al. 2008; Wolfe et al. 2008; Miller et al.
2009; Wolfe et al. 2014a, 2014b, 2017; Wolfe et al., 2014a,
b; Lapid and Shilo-Benjamini 2015). Medetomidine–midazo-
lam–butorphanol (MMB) is a drug combination used success-
fully for sedation of domestic and pet pigs in veterinary med-
icine (Wolff 2009). Butorphanol is an opiate partial agonist
with analgesic and sedative properties and few adverse effects.
Onset of action is rapid, with peak effect occurring 15–30 min
after administration, and duration of action lasting up to 4 h.
Pharmacological effects of this drug are potentiated when ad-
ministered with ketamine (Plumb 2008). Azaperone, a butyro-
phenone tranquilizer, produces sedation but no analgesia and
has been demonstrated to prevent the development or exacer-
bation of malignant hyperthermia in domestic pigs. Onset of
action is rapid (5–10min), and duration of action ranges from 2
to 4 h (Plumb 2008). Medetomidine is an α2-adrenergic ago-
nist that elicits sedation, anxiolysis, and analgesia. Adverse
effects include bradycardia, decreased respiration, hypother-
mia, and rarely, paradoxical excitation and apnea (Plumb
2008). Advantages include capability to reverse with
atipamezole. Midazolam is a benzodiazepine that produces
sedation, anxiolysis, and muscle relaxation. Adverse reactions
are primarily limited to respiratory depression. Duration of
action lasts an average of 2 h (1–6 h range) and is species
variable (Plumb 2008; Carpenter 2013). Nalbuphine is an opi-
oid partial agonist that produces sedation and limited analgesia.
Severe respiratory depression may occur when this drug is
used in combination with other central nervous system or re-
spiratory depressant agents. Advantages include the capability
to reverse with naloxone (Plumb 2008).
Here, we describe an exploratory study to assess and com-
pare the efficacy of four drug combinations, MMB, BAM™,
NalMed-A, and TZX, for wild pig immobilization. In addi-
tion, we measured levels of detectible drug in edible tissues at
multiple time points to monitor drug residues in this hunted
species.
Methods
Twenty-three captive-raised wild pigs (female = 13, male = 10;
offspring of wild pigs collected in Texas, USA) were used for
this study. Animals ranged in age from 5 to 7 months and
weights ranged from 12.27 to 30.00 kg at the beginning of
phase I and 16.35–43.64 kg during phase IV of the study.
Pigs were housed at the United States Department of
Agriculture (USDA)–Animal and Plant Health Inspection
Service (APHIS)/Colorado State University (CSU) Wildlife
Research Facility, Fort Collins, Colorado, USA (40°34′5″N,
105°08′49″W; elevation approximately 1519m). Animals were
held in 3m × 13m solid panel runs with soil substrate, andwere
offered a commercial swine ration fed at 0.5 kg/animal/day and
water ad libitum. The study plan was approved by the CSU
Animal Care and Use Committee (IACUC 17-7386A) and
the USDA–APHIS, Wildlife Services, National Wildlife
Research Center, Animal Care and Use Committee (QA-2803).
Medetomidine (40 mg/mL), midazolam (50 mg/mL),
butorphanol (30 mg/mL), and atipamezole (25 mg/mL) were
obtained individually, and BAM™ (butorphanol, 27.3 mg/
mL; azaperone, 9.1 mg/mL; medetomidine, 10.9 mg/mL)
and NalMed-A (nalbuphine, 40 mg/mL; azaperone, 10 mg/
mL; medetomidine, 10 mg/mL) were obtained as premixed
products from Wildlife Pharmaceuticals Inc., Windsor,
Colorado, USA. Tiletamine–zolazepam (Telazol® (tiletamine
50 mg/mL, zolazepam 50 mg/mL)) was obtained from Zoetis
(Parsippany, New Jersey, USA) and xylazine (AnaSed®
(100 mg/mL) from Lloyd Inc. (Shenandoah, Iowa, USA).
The study was conducted in four phases, each separated by
a 2-week wash-out period. The first and second phases were
used to optimize and test BAM™ and NalMed-A dosages,
respectively. The third phase was used to optimize and test
MMB dosages and to collect edible tissues from six test sub-
jects. During the fourth phase, six wild pigs were immobilized
with an established TZX dosage (TZ, 4.40 mg/kg; X,
2.5 mg/kg) (Ko et al. 1993; Sweitzer et al. 1997a, 1997b;
Enqvist 2000; Plumb 2008; Carpenter 2013) to obtain com-
parative pre-, intra-, and post-immobilization data and tissues
for residue testing, and six animals were immobilized with
BAM™ to obtain tissue residue samples.
Pigs were randomized into three treatment groups and were
fasted for 24 h prior to immobilization. Each animal was
weighed and manually restrained with a mechanical squeeze
in a pig-specific handling box (46.4 cm × 99.1 cm ×
68.58 cm). All drugs were delivered by hand injection intra-
muscularly (IM) deep into the lateral thigh using a 3.0-mL
syringe and 18G × 2 in. hypodermic needle. Immediately after
injection, restraint was removed and the handling box covered
to minimize stimulation. Each wild pig was monitored for
changes in behavior and levels of sedation. A dosage was
considered adequate for sedation when immobilization oc-
curred within 20 min, and allowed safe manipulation of the
animal and measurement of physiological parameters. Once
optimized dosages were determined, pigs remaining in the
respective treatment groups were chemically immobilized
and physiological parameters monitored.
The optimization procedure for BAM™ and NalMed-A
occurred as follows: The recommended starting dosage in
wild pigs for BAM™ (1.0 mL/45 kg IM; equivalent to
butorphanol 0.60 mg/kg, azaperone 0.20 mg/kg, and
medetomidine 0.22 mg/kg) or NalMed-A (1.5 mL/45 kg IM;
equivalent to nalbuphine 1.3 mg/kg, medetomidine
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0.33 mg/kg, and azaperone 0.33 mg/kg) were drawn directly
into a syringe and administered to the first wild pig. If sedation
for safe handling occurred within 20 min, the animal was
removed from the restraint box, eye lubrication ointment
(Paralube® Vet Ointment; Dechra Pharmaceuticals, Quebec,
Canada) was placed in each eye, a blindfold was applied, and
the animal was handled and monitored, followed by IM ad-
ministration of the antagonist drug (atipamezole 5.0 mg per
1.0 mg medetomidine administered). The animal was then
transferred to a recovery pen for recovery monitoring. A sec-
ond wild pig was restrained as described above and adminis-
tered a 10% decreased dosage of the candidate drug combina-
tion and observed for response. If this animal became ade-
quately sedated, it was monitored and recovered as described
above. Subsequent animals would then be administered 10%
decreasing dosages of the candidate drug combination until
adequate sedation could not be achieved. If the first wild pig
was inadequately sedated (safe handling not achieved 20 min
post-injection), it was administered the appropriate reversal
antagonist, moved to the recovery pen, and monitored until
full recovery. The second wild pig was subsequently admin-
istered a 20% increased dosage of the candidate drug combi-
nation and observed. This process would be repeated until an
adequate level of sedation was achieved. The next pig would
receive a 10% decreased dosage of the candidate drug combi-
nation to complete the drug optimization process.
MMB is not available commercially as a premixed drug
combination, requiring optimization of each drug in the com-
bination. The starting dosage for each drug was calculated
using previously published dosages for each drug component
(e.g., medetomidine 0.06 mg/kg; midazolam 0.3 mg/kg;
butorphanol 0.3 mg/kg) (Wolff 2009). Each drug was individ-
ually withdrawn from a stock bottle using separate syringes
and combined into one syringe for IM injection. If adequate
sedation was achieved, the animal was removed from the pig
handler and processed as described above, followed by ad-
ministration of the antagonist drug (atipamezole 5.0 mg for
every 1.0 mg medetomidine administered) and recovery mon-
itoring. Dosage adjustments for midazolam and butorphanol
were changed in 10% or 20% increments as described above.
The concentration of medetomidine was such that dosage ad-
justments were made in increments of 0.01 mL (0.04 mg).
Prior to administration of TZX, the two drug components
were drawn up individually then combined into one syringe
used for IM injection. Animals immobilized with TZX were
administered tolazoline HCl (Tolazine®; Lloyd Inc.),
2.2 mg/kg to antagonize xylazine.
Parameters
Induction was measured as time (min) from drug administra-
tion to level 2 (partial sedation, ataxia), level 3 (partial
sedation, sternal recumbency), and level 4 induction (lateral
recumbency, complete sedation). Chemically immobilized
wild pigs reaching level 4 sedation adequate for handling
20 min post-IM injection were monitored physiologically
(e.g., rectal temperature (T), heart rate (HR, beats/min), respi-
ratory rate (R, breaths/min), blood pressure (BP), peripheral
capillary oxygen saturation (SpO2)), and adequacy of sedation
was evaluated (e.g., 1 = poor through 5 = best) by assessing
muscle rigidity, jaw tone, and response to field handling pro-
cedures (e.g., loud noise; body repositioning; blood collec-
tion; ear tag placement).
Monitoring time began when animals reached level 4 se-
dation adequate for handling 20 min post-IM injection and
continued for 40 min (average time to work-up wild pigs in
the field) or 60 min post-injection (two randomly selected
individuals per treatment group) to assess the potential dura-
tion of immobilization. At the end of the monitoring period,
all wild pigs were administered the appropriate antagonist
drug, placed in a recovery pen, and monitored until full recov-
ery was documented. Recovery was measured as the time
(min) from antagonist administration to each level of recovery
(e.g., level 2, increased respiration; level 3, able to hold head
up; level 4, standing). Post-recovery behaviors were observed
until animals exhibited normal behaviors and appeared to be
experiencing no overt residual effects of the immobilization
agents.
Rectal temperature (T), HR, R, and SpO2 were monitored
and recorded every 5 min. A handheld pulse oximeter (Rad-
57; Masimo, Irvine, California, USA) and tongue sensor were
used to measure SpO2. Nasal insufflation of supplemental
oxygen was initiated at 3 L/min if SpO2 levels fell below
90%. Blood pressure was measured with an automated digital
blood pressure monitor (CONTEC08A Sphygmomanometer;
Contec Medical Systems Co., Ltd, Qinhuangdao, China) and
10–19mm pediatric cuff placed over the ulnar artery proximal
to the carpal joint (Hodgkin et al. 1982).
Tissue drug residues
Two wild pigs immobilized with MMB were euthanized dur-
ing phase III of the study 3, 5, and 7 days post-immobilization
and edible tissues (e.g., fat, liver, kidney, semitendinosis/
semimembranosis muscle) were collected to determine drug
residue levels (limit of detection 0.01 ppm). No wild pigs
immobilized with BAM™ during phase I were euthanized
in order to preserve adequate numbers of pigs throughout
phases II and III. Instead, during phase IV, six individuals
were immobilized with BAM™ and euthanized at the
above-stated time-points, as were the six TZX-immobilized
animals. Samples were stored at − 80 °C until analysis by
liquid chromatography–tandem mass spectrometry (LC–MS/
MS; Texas Veterinary Medical Diagnostic Laboratory, Texas
A&M University, College Station, Texas, USA).
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Assessment of measured parameters
Physiological parameters were evaluated observationally to
assess changes occurring over the course of the chemical im-
mobilization period for TZX and each successfully optimized
candidate chemical immobilization combination. Recorded
observations were compared to published normal values for
domestic and wild pigs (Sakaguchi et al. 1992; Ko et al. 1993;
Sweitzer et al. 1997a; Williams et al. 2002; Plumb 2008;
Carpenter 2013; Swindle and Smith 2015). Prior to initiating
statistical analyses, we visually assessed all data for normality
to determine themost suitable statistical methodology. Overall
mean HR, R, and T data and residuals appeared normally
distributed, and we used linear mixed models to assess the
effect of drug combinations on these parameters. For each
response variable, we used a fixed effect to describe the effect
of treatment group and sex. Range in weight was controlled
for by including weight as a random effect. We also accounted
for the random effect of individual in all models to account for
any variability between individual animals. The effect of each
drug combination on induction time to each level of sedation
and time from administration of antagonist to recovery level 4
were not normally distributed and were analyzed using a
Kruskal–Wallis test. We carried out all statistical analyses in
the R programming environment (http://www.R-project.org)
using the linear mixed model package lme4 and lmerTest.
Results
Drug optimization
Two drug combinations (MMB and BAM™) were success-
fully optimized in wild pigs (Table 1). The optimized BAM™
dosage was higher (1.2 mL/45 kg) than the suggested starting
dosage, and individual drug dosages for butorphanol and
medetomidine were greater than the published recommended
dosage ranges for swine (Sakaguchi et al. 1992; Plumb 2008;
Carpenter 2013; Swindle and Smith 2015). The optimized
individual MMB drug dosages all fell within recommended
dosage ranges for swine (Sakaguchi et al. 1992; Plumb 2008;
Carpenter 2013; Swindle and Smith 2015). Wild pigs admin-
istered optimized dosages of MMB and BAM™ remained
safely immobilized until antagonist administration, including
the two animals monitored for 60 min.
An effective NalMed-A dosage could not be determined.
The recommended dosage was incrementally increased to
2.0 mL/45 kg, which proved inadequate to produce a level
of sedation amenable to safe handling. Further increases in
dosage were deemed infeasible for safe or practical use.
Wild pigs administered NalMed-A were observed to reach
sedation levels 2, 3, and 4 at 7–15 min; 10–25 min; and 16–
37 min, respectively, but recovered quickly to standing when
stimulated by minor manipulations (e.g., taking T, touching
the face, removing the animal from the handler). When ani-
mals were moved to the recovery pens, they were often stand-
ing and fully mobile.
Induction and sedation quality
Observationally, the average time to level 2 sedation forMMB
and BAM™-treated wild pigs (3.8 min and 4.1 min, respec-
tively) were similar to the time noted in one TZX animal
(4.5 min; the other TZX-treated wild pigs progressed directly
to level 3) (Table 2). The average times to induction level 3
were similar for MMB and BAM™ (8.1 min and 7.8 min,
respectively) and longer than that observed for TZX
(4.0 min). Animals administered TZX reached level 4 induc-
tion faster (8.6 min) than those sedated with MMB (12.7 min)
or BAM™ (11.6 min). Statistically, time from administration
of MMB, BAM™, and TZX to sedation levels 2 and 4 were
not significantly different; however, time to reach level 3 was
statistically different (Kruskal–Wallis test p = 0.02) in the
MMB versus TZX, and BAM™ versus TZX comparisons.
There was no statistical difference in time to reach level 3
between BAM™ and MMB.
Good sedation quality was observed for MMB, BAM™,
and TZX. No responses were noted in any immobilized ani-
mals when they were removed from the restraint box, during
application of the SpO2 monitor, or during assessment of T,
HR, R, and BP throughout the monitoring period. Jaw tone
was comparatively relaxed, and no responses were observed
to loud noise, venipuncture, or when minor body reposi-
tioning (e.g., manipulating legs, placing in lateral recumben-
cy) occurred across all treatment groups; however, when
BAM™-immobilized wild pigs were placed in dorsal recum-
bency to mimic being weighed or transported without use of a
stretcher, we did observe vocal and movement responses in
some animals. Observationally, muscle rigidity was greater
during the first 15 min of the monitoring period when animals
were immobilized with TZX versus MMB and BAM™.
Reaction to ear tagging (i.e., ear flick) was observed in 5/14
(35%) of BAM™, 2/14 (14%) of MMB, and 1/6 (17%) TZX-
treated wild pigs.
Statistically, MMB and BAM™ did not differ in their ef-
fects on overall mean T, HR, and R while TZX differed sig-
nificantly in all three parameters from both MMB (p ≤
0.00001) and BAM™ (p ≤ 0.00513). Variation among indi-
viduals was high for all combinations, and males generally
had slightly but not significantly lower T, HR, and R values
than females. Weight did not account for any variation in the
model for T, was equal to individual variation in the model for
R, and accounted for most of the variation among individuals
in the model examining HR. Statistical analyses were not per-
formed on SpO2 or blood pressure.
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Observationally, the mean T recorded in MMB and
BAM™-treated wild pigs at the beginning of the monitoring
periods were within the normal T range reported for swine
(Kahn et al. 2005; Carpenter 2013; Morgaz et al. 2015) and
decreased to slightly below normal (Table 3). The mean T of
TZX-treated animals was above the upper limit of T normal at
the initiation of monitoring, and exceeded or remained in the
high normal range throughout the monitoring period.
Individually, the observed Tof 5/14 (36%) MMB- and 2/14
(14%) BAM™-immobilized wild pigs 20 min post-drug ad-
ministration approached or exceeded the normal T range; how-
ever, all temperatures fell within or slightly below normal dur-
ing continued monitoring. The T of 2/6 (33%) TZX-treated
individuals were above normal at the initiation of monitoring
and remained elevated, necessitating topical application of cool
water and alcohol, and cool water enemas were administered to
one individual that remained refractory to topical treatment.
Temperatures of the other TZX-treated animals were at the
upper limit of normal T at the initiation of monitoring and
remained higher than the T recorded for these individuals dur-
ing MMB and BAM™ sedation.
The mean HR of wild pigs immobilized with MMB and
BAM™ were similar and remained within normal HR limits
throughout the monitoring periods. By comparison, during
TZX immobilization, mean HR were observed to be higher
in all individuals, yet remained within normal limits. Mean R
were within normal limits when wild pigs were immobilized
with MMB and BAM™ and TXZ; however, R tended to be
lower throughout the monitoring periods when animals were
administered MMB and BAM™.
All wild pigs required administration of supplemental ox-
ygen regardless of the chemical immobilization agents used.
Mean SpO2 measurements recorded without oxygen supple-
mentation at the initiation of monitoring were 90%, 87%, and
91% for MMB, BAM™, and TZX, respectively. These values
recovered post-oxygen supplementation to mean measured
saturation levels of 93% (MMB), 93% (BAM™), and 93%
(TZX) at 40 min and 93% (MMB), 90%, and 98% (TZX) at
60 min. We were unable to consistently measure BP in all
animals at all time-points; however, when measured, systolic
and diastolic BPwere within normal limits based on published
values (Hodgkin et al. 1982; Gianotti et al. 2010).
Recovery
Average times to recovery level 4 after administration of ap-
propriate reversal agents were observed to be slightly shorter
when wild pigs were immobilized with MMB and BAM™
(7.5 min and 6.7 min, respectively) versus TZX (10.9 min)
(Table 2). Observationally, recovery quality following MMB
and BAM™ immobilization was improved over recoveries
observed following TZX immobilization. After administration
of atipamezole, wild pigs immobilized with MMB and
BAM™ quietly transitioned from lateral recumbency to ster-
nal recumbency or standing, then walked away or stood qui-
etly and were capable of coordinated purposeful movements.
Table 1 Drugs and drug
combinations evaluated for use as
chemical immobilization agents
used in captive wild pigs (Sus
scrofa) during comparison of
immobilization drugs
medetomidine, midazolam,
butorphanol (MMB);
butorphanol, azaperone,
medetomidine (BAM™); and
tiletamine–zolazepam, xylazine
(TZX)
Drug combination Optimized
drug dosage
Individual drugs Individual drug dosages
in combination (mg/kg)
Published dosage
rangesa (mg/kg)
MMB 0.06 mg/kg Medetomidine 0.06 0.03–0.15
0.30 mg/kg Midazolam 0.30 1.00–10.00
0.30 mg/kg Butorphanol 0.30 0.10–0.50
BAM™ 1.2 mL/45 kg Butorphanol 0.72 0.10–0.50
Azaperone 0.24 0.15–0.30
Medetomidine 0.27 0.03–0.15
TZX NA Tiletamine–zolazepam 4.40 2.0–4.4
Xylazine 2.50 2.0–2.50
NA not applicable
a Sakaguchi et al. 1992; Ko et al. 1993; Sweitzer et al. 1997a; Plumb 2008; Carpenter 2013; Swindle and Smith
2015
Table 2 Observed times to levels of induction and recovery for captive
wild pigs (Sus scrofa) during comparison of immobilization drugs
medetomidine, midazolam, butorphanol (MMB); butorphanol,
azaperone, medetomidine (BAM™); and tiletamine–zolazepam, xylazine
(TZX)
Drug combinations
Induction times
(mean min ± SD)
MMB
(N = 14)
BAM™
(N = 14)
TZX
(N = 6)
Level 2 (ataxia) 3.8 ± 0.6 4.1 ± 1.5 4.51
Level 3 (sternal recumbency) 8.1 ± 2.1a 7.8 ± 3.5a 4.0 ± 1.4b
Level 4 (lateral recumbency) 12.7 ± 1.5 11.6 ± 5.4 8.6 ± 3.3
Time to recovery1
Level 4 (standing) 7.5 ± 4.8 6.7 ± 3.5 10.9 ± 7.0
Values with different letters are significantly different from each other
1 Only one individual. All others progressed directly to level 3
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Complete recovery from immobilization was observed in all
MMB animals and all but two BAM™-treated individuals an
average of 2 h after standing. By comparison, the recoveries
observed in wild pigs following TZX immobilization were
rough. During progression from lateral recumbency to stand-
ing, observed behaviors in all animals included paddling,
struggling to rise, falling over, ataxia, and incoordination,
and attempts to run followed by falling to the ground or
against the sides of the recovery area. These behaviors and
muscle rigidity were observed in some individuals for
prolonged periods (45–90 min).
Morbidity and mortality
None of the pigs in the MMB group appeared to experience
behaviors or actions post-immobilization that might contrib-
ute to morbidity and there were no mortalities. Two BAM™-
treated pigs (14%) were observed vomiting, drooling, and
appeared depressed post-recovery. One animal appeared fully
recovered after 3 h, while the other remained depressed, an-
orexic, and sternally recumbent for 24 h before appearing fully
recovered. All animals immobilized with TZX experienced
rough recoveries and long post-recovery periods (i.e.,
90 min) that likely contributed to post-immobilization trauma,
stress, and morbidity. One animal exhibited symptoms of hy-
perthermia (i.e., panting) during recovery but was too frac-
tious to be re-captured for veterinary evaluation or interven-
tion. A second animal began panting, became laterally recum-
bent, and had a recorded T of 40.6 °C that returned to normal
limits after external application of alcohol and water. This
individual remained in lateral recumbency for 3 h, developed
mucoid bloody diarrhea, and died. Significant gross necropsy
findings included sub-endothelial hemorrhage in the ventric-
ular walls of the heart; a 4-mm2 vegetative lesion on the mitral
valve, and submucosal hemorrhage in the wall of the stomach
and duodenum. Histopathological findings were consistent
with vegetative endocarditis, recent aspiration of ingesta,
prolonged hypoxia, and hypotensive shock.
Tissue residues
No drug residues were found in any tissues collected from
pigs at 3 and 5 days post-MMB administration, but
medetomidine and butorphanol residues were identified in
fat collected from one animal 7 days after immobilization
(Table 4). Azaperone was found in the muscle tissues of one
pig 3 days after BAM™ administration, and azaperone or
butorphanol were identified in the tissues (muscle and fat,
respectively) of the two pigs euthanized 7 days post-BAM™
administration. Drug residues found in the tissues of the two
pigs euthanized 3 days after TZX sedation included
zolazepam (one pig; muscle and fat) and xylazine (both pigs;
liver, kidney). Xylazine residues were found in liver and kid-
ney tissues collected from one pig euthanized at day 5 post-
TZX sedation, and tiletamine (muscle), zolazepam (muscle,
fat), and xylazine (muscle, liver, kidney) residues were detect-
ed in tissues from the other day 5 TZX-treated pig. Xylazine
residues were identified in the liver and kidney tissues in one
TZX pig euthanized 7 days after treatment.
Discussion
The optimized dosage of MMB provided good chemical immo-
bilization and the most desirable recovery for wild pigs in this
study. Although mean induction time was 4.1 min longer than
that of TZX, this induction period is acceptable for both captive
and field use. Body temperatures decreased over the course of the
monitoring period, even in five wild pigs with initial Ts that
approached or exceeded normal published T ranges and received
no interventive treatment. Heart and R rates were within pub-
lished normal limits, and the only responses to manipulations
simulating field work occurred during ear tagging in five indi-
viduals (i.e., ear flick). Recoveries were smooth and rapid, and
few observable behaviors that might exacerbate morbidities were
observed. Animals remained quiet, but cognizant, capable of
purposeful movement, and able to interact with other members
Table 3 Range of physiological
parameters measured in captive
wild pigs (Sus scrofa) during
comparison of immobilization
drugs medetomidine, midazolam,
butorphanol (MMB) and
butorphanol, azaperone,
medetomidine (BAM™) to
tiletamine–zolazepam/xylazine
(TZX)
Drug protocol Temperature (°C) Heart rate
(beats/
min)
Respiratory rate
(breaths/min)
Blood pressure
(mm Hg)*
Normal* Minimum 38.85 50 10 152/109
Maximum 39.80 100 20 230/165
MMB (N = 14) Minimum 36.80 48 16 108/54
Maximum 40.30 104 70 191/128
BAM™ (N = 14) Minimum 35.60 38 16 122/50
Maximum 41.30 120 82 220/129
TZX (N = 6) Minimum 38.10 60 36 110/52
Maximum 41.10 116 78 203/122
*Hodgkin et al. 1982; Hannon et al. 1989; Plumb 2008; Gianotti et al. 2010; Sipos et al. 2013; Morgaz et al. 2015
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of their respective group post-recovery. There are multiple ad-
vantages relative to the use ofMMB for chemical immobilization
of wild pigs that are to be released after capture. The individual
drugs in the optimized combination are within published dosage
ranges (Sakaguchi et al. 1992; Ko et al. 1993; Plumb 2008;
Carpenter 2013; Swindle and Smith 2015) allowing for supple-
mental drug administration in the field, and relative safety if over-
dosage occurs. In addition to the good induction, sedation, and
recovery quality, all three drugs in the combination provide an-
algesia and muscle relaxation. The highly sedative effects of
medetomidine are reversible with atipamezole, allowing animals
to continue to benefit from the analgesic, anxiolytic, and sedative
effects of butorphanol and midazolam for 2–4 h. During this
interval, animals are still capable of purposeful responses to stim-
uli. Disadvantages of MMB include the possibility of bradycar-
dia with/without arrhythmia, the persistence of primary or sec-
ondary drug metabolites in tissues, and the requirement for con-
trolled substance documentation in some countries. Additionally,
this drug combination requires compounding to achieve concen-
trations optimal for combination, which in turn can lead to lim-
ited availability and increased cost.
Desirable induction,monitoring, recovery, and physiological
outcomes similar to those of MMB were noted when wild pigs
were immobilized with BAM™. Measured T of two individ-
uals exceeded upper normal T, but dropped within the normal
range with no intervention. From a handling perspective,
performing minor manipulations such as moving the body in
lateral recumbency, and adjusting or handling limbs and the
head elicited no responses; however, some individuals did
vocalize or appear to briefly arouse when placed in dorsal re-
cumbency and lifted by the limbs, as is often done in the field
for weighing or moving. Morbidity was observed in two ani-
mals for 3 and 24 h, respectively. We have observed similar
morbidity post-BAM™ immobilization in adult wild pigs that
were not part of this study (Nol, unpublished data). The dosage
of BAM™ required to reach optimal immobilization in this
study contained individual dosages of butorphanol and
medetomidine exceeding the upper limit of published dosage
ranges for swine (Plumb 2008; Carpenter 2013; Swindle and
Smith 2015). Potentiation of desirable (e.g., sedation, analgesia)
and undesirable (e.g., profound sedation, depression, nausea,
vomiting) effects may occur when medetomidine and opiates
such as butorphanol are used in combination (Plumb 2008;
Girard et al. 2010). It is plausible that the higher dosages of
these two drugs in the optimized BAM™ dosage produced the
clinical signs of morbidity observed. Use of naltrexone to an-
tagonize butorphanol might mitigate these effects; however, we
do not routinely administer naltrexone after BAM™ immobili-
zation, choosing instead to allow persistence of the pharmaco-
logical effects provided by butorphanol. Potentiation of effects
may occur when azaperone and atipamezole are administered,
which could increase the potential for the side effects observed
as well (Clark and England 1989; Sinclair 2003; Woodward
2005; Riviere and Papich 2013). Azaperone may undergo de-
layed absorption via sequestration in body fat, which may elicit
persistence or recurrence of sedation and adverse effects
(Plumb 2008). Other disadvantages associated with BAM™
may include bradycardia with/without arrhythmia and retention
Table 4 Drug residues detected in selected tissues collected from wild pigs (Sus scrofa) on days 3, 5, and 7 post-administration of medetomidine–
midazolam–butorphanol (MMB); butorphanol–azaperone–medetomidine (BAM™); or tiletamine/zolazepam–xylazine (TZX)
Drug combination Animal Days post-immobilization Muscle Fat Liver Kidney
BAM™ 1 3 Azaperone ND ND ND
2 3 ND ND ND ND
3 5 ND ND ND ND
4 5 ND ND ND ND
5 7 Azaperone ND ND ND
6 7 ND Butorphanol ND ND
MMB 1 3 ND ND ND ND
2 3 ND ND ND ND
3 5 ND ND ND ND
4 5 ND ND ND ND
5 7 ND ND ND ND
6 7 ND Medetomidine Butorphanol ND ND
TZX 1 3 ND ND Xylazine Xylazine
2 3 Zolazepam Zolazepam Xylazine Xylazine
3 5 ND ND Xylazine Xylazine
4 5 Tiletamine Zolazepam Xylazine Zolazepam Xylazine Xylazine
5 7 ND ND Xylazine Xylazine
ND not detected
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of primary or secondary drug metabolites in tissues. Like
MMB, BAM™ is expensive and may require controlled sub-
stance documentation. It is possible that optimizing the individ-
ual constituents in BAM™ and addition of naltrexone as a
second reversal agent might result in both successful immobi-
lization and reduced post-recovery side effects. This was be-
yond the scope of this study, but warrants further investigation.
Tiletamine–zolazepam/xylazine produced the least favorable
statistical and observational outcomes relative to T, recovery
quality, morbidity, and mortality. Importantly, individual and
mean recorded Ts at the initiation of the monitoring period were
at or exceeded the upper limit of normal, and remained so
throughout the monitoring period in all TZX-immobilized in-
dividuals. One wild pig experienced presumed hyperthermia
post-recovery but recoveredwithout intervention, while another
individual experienced documented hyperthermia and died de-
spite interventive care. It should be noted that this animal was
successfully immobilized with bothMMB and BAM™ prior to
administration of TZX despite gross pathologic and histopath-
ologic findings indicating the presence of underlying patho-
physiology. Recoveries were rough in all TZX-immobilized
wild pigs, and behaviors and activities that likely lead to trauma
and morbidity were observed for periods up to 90 min after
animals reached level 4 recovery status. While the advantages
of TZX include shorter induction time, dissociative anesthesia,
analgesia, and anxiolysis, the long duration of action (1.5–
5.5 h), documented side effects, and our observed recovery-
related morbidity and mortality are of concern, especially if
wild pigs are to be released after immobilization for study pur-
poses. Acute cardiopulmonary arrest and 0.35% mortality fol-
lowing administration of TZ with or without K or X in combi-
nation have been reported in domestic and feral cats (Hughes
et al. 1996; Williams et al. 2002), and pre-existing pulmonary
and renal disease have been causally implicated as causes of
death in cats and dogs following administration of TZ (Plumb
2008). This information is of concern given that the pre-existing
health status of wild pigs in the field is unknown prior to im-
mobilization. However, given its rapid induction, low cost, and
consistent availability to date, this combinationmay be themost
practical and feasible drug combination in some situations.
Adequate sedation for safe handling was not achieved
using NalMed-A at dosages approaching double the recom-
mended starting dosage. As such, it appears that the concen-
trations of nalbuphine, medetomidine, and azaperone present
in the pre-mixed formulation used in this study were not effi-
cacious in wild pigs. As with BAM™, future studies designed
to optimize the individual drugs may lead to developing an
effective combination.
The initial SpO2 of all immobilized wild pigs, regardless of
treatment, was less than or equal to 90% and improved after
initiation of oxygen via nasal insufflation. Most immobilization
and anesthetic agents cause CNS-derived respiratory depression,
relaxation of respiratory musculature, ventilation and perfusion
mismatching, and other physiological events that contribute to
development of hypoxemia, leading to tissue hypoxia, myocar-
dial ischemia, organ failure, and rhabdomyolysis (Adamson and
Mills 1996; Moresco et al. 2001; Read 2003). Attempts to con-
sistently obtain arterial blood samples were unsuccessful; how-
ever, administration of oxygen via nasal insufflation has been
demonstrated effective in increasing arterial partial pressure of
oxygen in other ungulate species during chemical immobiliza-
tion (Paterson et al. 2009). It is therefore advisable to administer
supplemental oxygen when immobilizing wild pigs regardless
of the immobilization agents used.
Primary drug residues attributable to MMB administration
and reversal were detected in tissues collected from one pig at
day 7 post-immobilization. Residues associated with BAM™
immobilization and reversal were identified at days 3 and 7,
while residues attributable to TZX treatment and reversal were
found in tissues on days 3, 5, and 7. We did not test tissues for
secondary metabolites that might have a negative impact on
consumption. These results represent an area of future work,
and should include extended tissue sampling time points to
better assess the duration of primary drug and secondary me-
tabolite persistence due to the potential for consumption of
treated wild pigs by humans or wild animals.
Strengths of this study included our opportunity to optimize
and evaluate new chemical immobilization drug combinations
for wild pigs (MMB, BAM™) against a drug combination
(TZX) commonly utilized for immobilization of wild pigs in a
controlled setting, using captive reared wild pigs. Thus, while
the genetics of the pigs varied, we were able to control for a
number of variables including age, health status, weight, diet,
environment, and other factors, which is ideal for research and
development of untested products in animal species.We admin-
istered each candidate drug combination to all wild pigs in the
study, and TZX to one group of randomly selected wild pigs
that had been previously immobilized with MMB or BAM™.
This allowed us to directly compare the effects of the immobi-
lization agents on an individual and group basis, and helped
control for changes in animal age and weight over time.
The fact that the wild pigs used in this study were captive
reared and subjected to minimal environmental variability and
stress may be viewed as behavioral confounding; however,
while these pigs were habituated to human presence, routine
handling was minimal. The animals, therefore, retained many
of the behavioral attributes of the adult wild pigs on the pre-
mises. The age of the pigsmay have resulted in some age-related
bias relative to the effects of the chemical immobilization agents.
We were unable to control for age; however, weight was con-
trolled for in the statistical analysis. Despite these weaknesses,
we felt that evaluating chemical immobilization agents that have
limited or zero use data available in wild pigs in an environment
that allowed us to control for as many factors as possible super-
seded the idea of attempting this study in the field where the
number of confounding variables would be even greater.
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It is to be expected that adjustments in dosages will be
required when immobilizing free-ranging wild pigs of variable
age and size that are experiencing increased levels of stress due
to capture methods, environment, reduced nutrition, compro-
mised health, or other factors (Barasona et al. 2013), and this
challenge represents an area of future study. To date, we have
administered the optimized dosage and adjusted dosages of
MMB (medetomidine 0.08–0.11 mg/kg; midazolam 0.42–
0.55 mg/kg; butorphanol 0.42–0.55 mg/kg) and BAM™
(1.3–1.7 mL/45 kg) to aggressive, fractious wild pigs ranging
in weight from 37 to 170 kg in the field with excellent chemical
immobilization results, and increased levels of safety for both
the wild pigs and the human handlers (Ellis, unpublished data).
Important goals of wildlife field research include the safety
of the human operators and animals, and handling of the re-
search subjects in a manner that contributes to release of ani-
mals that are as healthy as possible in order to obtain the most
relevant research data possible. Highly stressed, injured, pain-
ful, or compromised animal subjects will not produce good
data. Therefore, development and use of handling methods
designed to limit exertion, stress and injury, and use of revers-
ible chemical immobilization agents that provide hypnosis,
amnesia, analgesia, and muscle relaxation without undesirable
changes in T, HR, R, and other physiological parameters dur-
ing the peri- and post-immobilization periods are important
for successful field research in wild pigs.
In conclusion, use of chemical immobilization agents that
offer rapid induction, good quality immobilization, and rapid,
quiet recovery with residual analgesia, and few persistent or
potentially detrimental post-recovery effects should be used
when field research requires safe handling and release of wild
pigs back into the environment. A frequent goal of capture and
release–based field research is to monitor wild pigs behaving
naturally in the environment. Pharmacologically, some dura-
tion of action effects persist beyond the time that animals
appear recovered from immobilization (i.e., standing, capable
of movement). Therefore, post-recovery effects, and the dura-
tion of those effects, should be considered when selection of
the most appropriate chemical immobilization agent is made.
Based upon our findings, we conclude that MMB appears
to be the safest, most efficacious of the drug combinations
compared in this study. This drug combination provides im-
proved immobilization, recovery, and post-recovery effects
relative to wild pig physiological responses, safety, morbidity,
and mortality compared to BAM™ and TZX. In the event that
MMB is not available for use, BAM™ constitutes our second
recommendation for wild pig immobilization because physi-
ological responses, recovery quality, and post-recovery behav-
iors are similar to that of MMB, and the incidence of morbid-
ity, while troubling, is low. In comparison, TZX produces less
desirable results relative to T, and results in behaviors and
activity during and after recovery for prolonged periods that
contribute to trauma, injury, prolonged exertion and stress,
and post-release morbidities (i.e., hyperthermia, capture my-
opathy), or mortality. Our observations of complications oc-
curring during wild pig immobilization with TZX are support-
ed by anecdotal and documented reports in the literature
(Gabor et al. 1997; Sweitzer et al. 1997a, 1997b; Enqvist
2000; Wyckoff et al. 2006; Kim et al. 2007; Fenati et al.
2008; Barasona et al. 2013). If researchers intend to use
TZX in the field, they must be prepared to mitigate undesir-
able side effects, especially when wild pigs are to be released.
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